Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364501
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-04-02
Brief Title:
Phase 1 Trial of KH801
Sponsor:
Beijing Kanghong Biopharmaceutical Co Ltd
Organization:
Chengdu Kanghong Pharmaceutical Group Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-02
First Submit QC Date:
April 9 2024
Study First Post Date:
2024-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2024-04-17
Last Update Post Date Type:
ACTUAL